In vitro generation of Epstein-Barr virus-specific cytotoxic T cells in patients receiving haplo-identical allogeneic stem cell transplantation

Journal of Immunotherapy

Volumn 24, Issue 4, 2001, Pages 312-322

  Musk, P ^a   Szmania, S ^a   Galloway, A ^a   Johnson, K ^a   Scott, A ^a   Guttman, S ^a   Bridges, K ^a   Bruorton, M ^a   Gatlin, J ^a   Garcia, J V ^a   Lamb, L ^a   Chiang, K Y ^a   Spencer, T ^a   Henslee Downey, J ^a   Van Rhee, F ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Cytotoxic T lymphocytes; Epstein Barr virus; Haplo identical BMT

Indexed keywords

BETA1 INTEGRIN; CD45 ANTIGEN; HLA DR ANTIGEN; L SELECTIN; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CELL ADHESION; CELL CLONE; CELL POPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; EPSTEIN BARR VIRUS; FEMALE; HUMAN; IN VITRO STUDY; LYMPHOBLASTOID CELL LINE; MALE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL TRANSPLANTATION; TISSUE CULTURE;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CELL LINE; CELL LINE, TRANSFORMED; CHILD; EPITOPES; FEMALE; GENES, BCL-2; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOPHENOTYPING; LENTIVIRUS; MALE; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTES, CYTOTOXIC; TRANSDUCTION, GENETIC;

EID: 17944381369     PISSN: 10538550     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002371-200107000-00007     Document Type: Article

References (35)

1. Use of partially mismatched related donors extends access to allogeneic marrow transplant
2. Risk of lymphoproliferative disorders after bone marrow transplantation: A multi institutional study
3. Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection
4. The role of Epstein-Barr virus subtypes in human immunodeficiency virus-associated lymphoma
5. Projections of the incidence of non-Hodgkin's lymphoma related to acquired immunodeficiency syndrome
6. Principals of tumor immunity: Immunocompromised patients
7. Orthotopic liver transplantation, Epstein-Barr virus, cyclosporine, and lymphoproliferative disease: A growing concern
8. Lymphoproliferative disorders involving Epstein-Barr virus after hematopoietic stem cell transplantation
9. Post transplantation lymphoproliferative disorders in bone marrow transplants recipients are aggressive diseases with a high incidence of adverse histologic and immunobiologic features
10. Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation
11. Donor T cells to treat EBV-associated lymphoma
12. Biology and adoptive cell therapy of Epstein-Barr virus-associated lymphoproliferative disorders in recipients of marrow allografts
13. Semi-quantitative Epstein-Barr virus (EBV) polymerase chain reaction for the determination of patients at risk from EBV-induced lymphoproliferative disease after stem cell transplantation
14. Use of gene-modified virus-specific T-lymphocytes to control Epstein-Barr-virus-related lymphoproliferation
15. Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus induced lymphoma in allogeneic transplant recipients
16. Predominant TCR-alpha beta variable and joining gene expression by muscleinfiltrating lymphocytes in the idiopathic inflammatory myopathies
17. Analysis of the T cell repertoire using the PCR and specific oligonucleotide primers
18. Differentiation and expansion of lentivirus vector-marked dendritic cells derived from human CD34+ cells
19. Efficient transduction of human lymphocytes and CD34+ cells via human immunodeficiency virus-based gene transfer vectors
20. Lymphoproliferative disorders in organ transplant recipients
21. Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T-lymphocytes
22. Apoptosis and Bcl-2 expression in cultured murine splenic T cells
23. Expression of Bcl-2, Bcl-x, and Bax after T cell activation and IL-2 withdrawal
24. Differential regulation of bcl-2 and bcl-x by CD3, CD28, and the IL-2 receptor in cloned CD4+ helper T cells. A model for the long-term survival of memory cells
25. Cutting edge: Increased expression of bcl-2 in antigen-specific memory CD8+ T cells
26. Factors that influence activated CD8+ T-cell apoptosis in patients with acute herpesvirus infections: Loss of costimulatory molecules CD28, CD5 and CD6 but relative maintenance of Bax and Bcl-X expression
27. Characterization of the expanded T cell population in infectious mononucleosis: Apoptosis, expression of apoptosis-related genes, and Epstein-Barr virus (EBV) status
28. Risks of developing Epstein-Barr virusrelated lymphoproliferative disorders after T-cell-depleted marrow transplants
29. CD20 monoclonal antibody (rituximab) for therapy of Epstein-Barr virus lymphoma after hemopoietic stem-cell transplantation
30. Simultaneous ex vivo expansion of cytomegalovirus and Epstein-Barr virus-specific cytotoxic T lymphocytes using B-lymphoblastoid cell lines expressing cytomegalovirus pp65
31. A phase I-II trial to examine the toxicity of CMV- and EBV-specific cytotoxic T lymphocytes when used for prophylaxis against EBV and CMV disease in recipients of CD34-selected/T cell-depleted stem cell transplants
32. Isolation and expansion of cytomegalovirus specific cytotoxic T lymphocytes to clinical scale using dendritic cells and HLA-tetramers
33. Generating cytotoxic T lymphocytes against cervical cancer with lentivirus-transduced antigen-presenting cells
34. Human papilloma virus in melanoma biopsy specimens and its relation to melanoma progression